Castle Biosciences, Inc. (CSTL)
27.72
-0.27
(-0.96%)
USD |
NASDAQ |
Mar 03, 14:56
Castle Biosciences Total Liabilities (Quarterly) : 138.34M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 899.65M |
| Delcath Systems, Inc. | 50.77M |
| Assertio Holdings, Inc. | 213.97M |
| CorMedix, Inc. | 376.73M |
| Harmony Biosciences Holdings, Inc. | 401.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 609.21M |
| Shareholders Equity (Quarterly) | 470.87M |
| Debt to Equity Ratio | 0.0786 |
| Current Ratio | 5.258 |
| Net Debt Paydown Yield | -0.18% |